200 related articles for article (PubMed ID: 35288231)
1. Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia.
Yan Y; Upadhyaya R; Zhang VW; Berg T
Exp Hematol; 2022 May; 109():1-10.e1. PubMed ID: 35288231
[TBL] [Abstract][Full Text] [Related]
2. Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy.
Yang G; Wang X; Huang S; Huang R; Wei J; Wang X; Zhang X
Front Immunol; 2022; 13():1034438. PubMed ID: 36268012
[TBL] [Abstract][Full Text] [Related]
3. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T; Velázquez GF; Schmid C
Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
[TBL] [Abstract][Full Text] [Related]
4. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Lee CJ; Savani BN; Mohty M; Gorin NC; Labopin M; Ruggeri A; Schmid C; Baron F; Esteve J; Giebel S; Ciceri F; Nagler A
Bone Marrow Transplant; 2019 Apr; 54(4):519-530. PubMed ID: 30104717
[TBL] [Abstract][Full Text] [Related]
5. Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.
Hilger N; Mueller C; Stahl L; Mueller AM; Zoennchen B; Dluczek S; Halbich C; Wickenhauser C; Gerloff D; Wurm AA; Behre G; Kretschmer A; Fricke S
Front Immunol; 2018; 9():2408. PubMed ID: 30405611
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.
Tang Y; Zhou Z; Yan H; You Y
Front Immunol; 2022; 13():810284. PubMed ID: 35185899
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy.
Al-Shaibani E; Novitzky-Basso I; Mattsson J; Kim DDH
Int J Hematol; 2023 Jul; 118(1):1-17. PubMed ID: 37212948
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
Christopher MJ; Petti AA; Rettig MP; Miller CA; Chendamarai E; Duncavage EJ; Klco JM; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Wilson RK; Wartman LD; Welch JS; Heath SE; Baty JD; Payton JE; Graubert TA; Link DC; Walter MJ; Westervelt P; Ley TJ; DiPersio JF
N Engl J Med; 2018 Dec; 379(24):2330-2341. PubMed ID: 30380364
[TBL] [Abstract][Full Text] [Related]
10. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.
Knorr DA; Goldberg AD; Stein EM; Tallman MS
Leuk Lymphoma; 2019 Dec; 60(14):3350-3362. PubMed ID: 31335250
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia.
Sterling C; Webster J
Am J Hematol; 2020 May; 95(5):529-547. PubMed ID: 32022292
[TBL] [Abstract][Full Text] [Related]
13. Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Gyurkocza B; Gutman J; Nemecek ER; Bar M; Milano F; Ramakrishnan A; Scott B; Fang M; Wood B; Pagel JM; Baumgart J; Delaney C; Maziarz RT; Sandmaier BM; Estey EH; Appelbaum FR; Storer BE; Deeg HJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):549-55. PubMed ID: 24440648
[TBL] [Abstract][Full Text] [Related]
14. Deregulated Expression of Circular RNAs Is Associated with Immune Evasion and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Zhao F; Zhang X; Pei X; Yang D; Han M
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360223
[TBL] [Abstract][Full Text] [Related]
15. Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.
Hattori N; Nakamaki T
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027331
[TBL] [Abstract][Full Text] [Related]
16. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes.
Kekre N; Koreth J
Curr Opin Hematol; 2015 Mar; 22(2):116-22. PubMed ID: 25575033
[TBL] [Abstract][Full Text] [Related]
17. Maintenance therapy in acute myeloid leukemia: What is the future?
McMahon CM; Luger SM
Semin Hematol; 2019 Apr; 56(2):102-109. PubMed ID: 30926085
[TBL] [Abstract][Full Text] [Related]
18. Haploidentical
Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
[TBL] [Abstract][Full Text] [Related]
19. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
Klusmann JH; Reinhardt D; Zimmermann M; Kremens B; Vormoor J; Dworzak M; Creutzig U; Klingebiel T
Haematologica; 2012 Jan; 97(1):21-9. PubMed ID: 21933851
[TBL] [Abstract][Full Text] [Related]
20. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?
Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø
Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]